Context Therapeutics Shares Surge On Encouraging Data From Onapristone In Early Breast Cancer
December 10, 2021 at 06:45 AM EST
Context Therapeutics Inc(NASDAQ: CNTX) posteddata from the window-of-opportunity trialof onapristone extended-release ...